{{Rsnum
|rsid=4364254
|Gene=HPSE
|Chromosome=4
|position=83302560
|Orientation=plus
|GMAF=0.3402
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=HPSE
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 12.4 | 37.2 | 50.4
| HCB | 6.6 | 38.2 | 55.1
| JPT | 2.7 | 36.6 | 60.7
| YRI | 24.8 | 51.0 | 24.1
| ASW | 24.6 | 52.6 | 22.8
| CHB | 6.6 | 38.2 | 55.1
| CHD | 7.5 | 39.3 | 53.3
| GIH | 10.9 | 41.6 | 47.5
| LWK | 26.9 | 50.0 | 23.1
| MEX | 5.3 | 50.9 | 43.9
| MKK | 31.4 | 51.3 | 17.3
| TSI | 8.8 | 43.1 | 48.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19406828
|Title=Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation
|OA=1
}}

{{PMID Auto
|PMID=20075159
|Title=Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors
|OA=1
}}

{{PMID Auto
|PMID=22276173
|Title=Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern chinese population
|OA=1
}}

{{PMID Auto
|PMID=17095861
|Title=Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel.
}}

{{PMID Auto
|PMID=17611567
|Title=Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
}}

{{PMID Auto
|PMID=24319286
|Title=Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}